Abstract
The liver is a common site of metastatic disease following initial spread to the lymph nodes, and, because it is the first major organ reached by venous blood draining from the intestinal tract, it is the most common site of metastatic disease from primary cancer within the abdomen. For patients with systemic spread of metastases, curative treatment is generally not possible and general chemotherapeutic approaches to treatment are indicated. On the other hand, if the liver remains the only site of metastatic disease, surgical resection may represent the only means of cure. Unfortunately, the average survival time of patients with untreated hepatic metastases is between 2 and 8 months [19].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bown SG. Phototherapy in tumors. World J Surg 1983 Nov; 7 (6): 700–9
Braga L, Semelka RC, Pedro MS, de Barros N. Post-treatment malignant liver lesions. MR imaging. Magn Reson Imaging Clin N Am 2002 Feb;lO(1):53–73
Chen HS, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep I980 Jan;64(1):3I-40
De Santis M, Torricelli P, Cristani A, Cioni G, Montanari N, Sardini C, Ventura E, Romagnoli R. MRI of hepatocellular carcinoma before and after transcatheter chemoembolization. J Comput Assist Tomogr 1993 Nov-Dec; 17 (6): 901–8
De Santis M. Alborino S, Tartoni PL, Torricelli P. Casolo A, Romagnoli R. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 1997; 7 (1): 10–6
Desinger K, Stein T, Tschepe J, Müller G. Investigation on radio-frequency current application in bipolar technique for interstitial thermotherapy (RF-ITT). Minim Invasive Med 1996: 7: 92–97
Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002 Apr; 223 (1): 255–62
Ebara M, Ohto M, Sugiura N, Kita K. Yoshikawa M, Okuda K, Kondo F, Kondo Y. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 1990 Nov-Dec; 5 (6): 616–26
Gayowski Ti, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994 Oct;116(4):703–10; discussion 710–1
Lee F, Bahn DK, McHugh TA, Onik GM, Lee FT Jr. US-guided percutaneous cryoablation of prostate cancer.Radiology 1994 Sep; 192 (3): 769–76
I Lencioni R, Bartolozzi C, Caramella D, Di Coscio G. Management of adenomatous hyperplastic nodules in the cirrhotic liver: US follow-up or percutaneous alcohol ablation? Abdom Imaging 1993; 18 (1): 50–5
McCarter MD, Fong Y. Metastatic liver tumors. Semin Surg Oncol 2000 Sep Oct; 19 (2): 177–88
Murakami T, Nakamura H, Tsuda K, Nakanishi K, Hori S, Tomoda K, Mitani T, Kozuka T, Monden M, Wakasa K. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging. AJR Am J Roentgenol 1993 Feb; 160 (2): 295–9
Pentecost MJ. Transcatheter treatment of hepatic metastases. AJR Am J Roentgenol 1993 Jun; 160 (6): 1171–5
Sakurai M, Okamura J, Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 1984 Aug 1: 54 (3): 387–92
Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K. Hamada E, Takahashi M, Shiratori Y, Terano A, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AIR Am J Roentgenol 1993 May; 160 (5): 1023–8
Sironi S, De Cobelli F, Livraghi T, Villa G, Zanello A, Taccagni G, DelMaschio A. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up. Radiology 1994 Aug; 192 (2): 407–12
Solbiati L, Goldberg SN, Ierace T, Livraghi T. Meloni F. Dellanoce M, Sironi S, Gazelle GS. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997 Nov; 205 (2): 367–73
Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994 Jun 4; 343 (8910): 1405–10
Steele G Jr. Cryoablation in hepatic surgery. Semin Liver Dis 1994 May; 14 (2): 120–5
Vogl TI, Muller PK, Mack MG, Straub R. Engelmann K, Neuhaus P. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 1999; 9 (4): 675–84
Vogl TJ, Mack MG, Muller PK, Straub R, Engelmann K, Eichler K. Interventional MR: interstitial therapy. Eur Radiol 1999; 9 (8): 1479–87
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Italia
About this chapter
Cite this chapter
Schneider, G., Grazioli, L., Saini, S. (2003). Imaging of the Liver Post-Surgery and/or Post-Ablative Therapy. In: Schneider, G., Grazioli, L., Saini, S. (eds) MRI of the Liver. Springer, Milano. https://doi.org/10.1007/978-88-470-2946-0_7
Download citation
DOI: https://doi.org/10.1007/978-88-470-2946-0_7
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2948-4
Online ISBN: 978-88-470-2946-0
eBook Packages: Springer Book Archive